PTPN11 and Noonan syndrome: Autosomal-dominant mutations in Ptpn11, which have been detected in approximately half of the patients with Noonan syndrome, predispose affected individuals to juvenile myelomonocytic leukemia and several other neoplasms that exhibit increased SHP2 phosphatase activity [19–21].